We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Divi’s Laboratories has been warned by the FDA for failing to meet current good manufacturing practice requirements, adding to the Indian drug manufacturer’s compliance woes. Read More
The U.S. Supreme Court heard oral arguments Tuesday over the jurisdiction for injury cases against Bristol-Myers Squibb related to its Plavix blood thinner. Read More